GL1X · GenesisL1 explorer

Research workbench

Three-dimensional structure of a SIV PROTEASE(SLASH)INHIBITOR complex. implications for the design of HIV-1 and HIV-2 protease inhibitors

Analyse Three-dimensional structure of a SIV PROTEASE(SLASH)INHIBITOR complex.… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1SIV
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SIV protease
UniProt
Q07387
Ligands
PSI
Pockets
1 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 6% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BSIV proteaseprotein996% helix, 53% strandQ07387

Ligands and binding sites

  • PSI · methyl N-{(4S,5S)-5-[(L-alanyl-L-alanyl)amino]-4-hydroxy-6-phenylhexanoyl}-L-valyl-L-valinate · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12690.700.8432PSI

Interfaces

1 interface between chains.

  • A–B · 1712 Ų buried · 45 hydrogen bonds · protein-protein

Compared structures

  • 1SIV · Three-dimensional structure of a SIV PROTEASE(SLASH)INHIBITOR complex. implications for… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.